InnoCan Pharma (TSE:INNO) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Innocan Pharma has announced promising results from a safety assessment of its LPT-CBD injectable on minipigs, showing excellent tolerance and no adverse effects. This study supports the feasibility of LPT-CBD’s safety evaluations, paving the way for future regulatory milestones in chronic pain treatment.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.
